Phenytoin (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Phenytoin drug offered from Actavis Pharma, Inc.. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Phenytoin |
| SUBSTANCE NAME: | PHENYTOIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-05-03 |
| END MARKETING DATE: | 2017-12-31 |
Phenytoin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Phenytoin from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/5mL) |
| START MARKETING DATE: | 2003-05-03 |
| END MARKETING DATE: | 2017-12-31 |
| PRODUCT ID: | 0472-5002_3476ace6-5dc0-4374-8ac0-badde7609c71 |
| PRODUCT NDC: | 0472-5002 |
| APPLICATION NUMBER: | ANDA089892 |
Other PHENYTOIN Pharmaceutical Manufacturers / Labelers:
